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Objectives: This study examined whether metabolic syndrome (MetS) would moderate the association
of cognition with frailty in middle and old age.
Methods: A cross-sectional design was used. Six hundred and ninety participants (age≥ 50 years) from
an on-going national survey were included in the study. Confirmatory factor analysis was applied to
determine latent variables of executive function (EF), episodic memory (EM), and MetS based on
relevant measurements. Frailty was defined using a modified form of Fried’s criteria.
Results:Applying structural equationmodeling, havingMetS significantly increased the likelihood of being
frail. Better performance on EM tasks, but not EF, was significantly associated with lower likelihood of
MetS. Worse performance on EF, but not EM, significantly increased the likelihood of being frail.
There was a significant interacting effect between MetS and EF, but not EM, on frailty. Further contrast
analysis indicated that having MetS strengthened the negative association between EF and frailty.
Conclusion:Metabolic syndrome moderates the relationship between EF and frailty. A prospecitve study
is needed to validate such relationships before developing interventions targeting the prevention or
treatment of EF and frailty in individuals with MetS. Copyright # 2014 John Wiley & Sons, Ltd.
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Frailty presents as a declined ability to respond to
stressful events and an increased vulnerability to
adverse health outcomes (Fried et al., 2001). Frail
individuals perform poorly on cognitive assessments;
more importantly, a number of longitudinal studies
suggest baseline cognitive function predicts the
incidence of frailty prospectively (Aranda et al., 2011;
Raji et al., 2011; Doba et al., 2012). Although these
studies provide support for a strong relationship
between cognition and frailty, whether other health
conditions moderate this relationship is not known.
Given the high prevalence of co-morbidity in middle
and old age, it is likely the relationship between frailty
and cognition does not occur in isolation but rather in
a context of other diseases and chronic conditions that
may exert influence on the relationship between frailty
and cognition (Robertson et al., 2013). Understanding
how the relationship between cognition and frailty is
affected by other health conditions may shed light on
shared underlying mechanisms and identify those
individuals for whom the relationship between frailty
and cognition is particularly strong, leading to
improved targeting of preventative and/or manage-
ment strategies.
An area of great interest is whether cognitive
decline and the development of frailty share biological
risk factors. Robertson et al., proposed several poten-
tial factors including Alzheimer’s disease pathology,
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hormones, nutrition, chronic inflammation, mental
health, and cardiovascular risk, but there is a lack of
experimental evidence to support these suggestions
(Robertson et al., 2013). Metabolic syndrome is a
involving the co-occurrence of several biological risk
factors and is recognized as an important health condition
indicative of risk for future development of adverse
cardiovascular events (Grundy et al., 2004). Metabolic
syndrome (MetS) has also been associated with declines
in cognition and incident frailty, separately (Adults,
2001; Afilalo et al., 2009; Panza et al., 2011). The preva-
lence of MetS ranges between 23% and 46% in middle
and old age, and MetS develops earlier than most chronic
conditions, thus making it an important target for early
prevention (Weiss et al., 2013). In a recent review, Barzilay
and Stein proposed that MetS leads to “accelerated aging”
processes of which frailty and cognitive decline are two of
the major noncardiovascular complications (Barzilay and
Stein, 2011). However, whether the presence of MetS
affects the relationship between cognition and frailty has
not been examined. If MetS does affect the relationship,
it may be an important marker for identifying those
individuals most at risk for experiencing cognitive decline
and becoming frail.
The purpose of the current study was to examine the
relationships among cognition, MetS, and frailty in a
group of adults aged 50 years or older; specifically, we
tested whether MetS would moderate the relationship
between cognition and frailty. To maximize the sensi-
tivity of measurements for cognition and MetS, instead
of simply using composite scores, we applied a confir-
matory factor analysis (CFA) approach to develop
latent variables of MetS and cognition using relevant
indicators (ATP III, 2001; Lachman et al., 2011). We
also employed structural equation modeling (SEM) to
simultaneously examine the main and interacting
effects of these latent variables on frailty.
Methods
Participants
This cross-sectional study used data from the second
wave of the Survey of Midlife Development in the
United States (MIDUS II), a nationally representative
database. There are five categories of assessments in
MIDUS II as follows: sociodemographic and
psychobehavioral survey (project 1), daily diaries
(project 2), cognitive function (project 3), biomarkers
(project 4), and neuroscience (project 5). A total of
4963 individuals participated in MIDUS II. Data from
projects 1, 3, and 4 was used for this analysis. There were
a total of 1255 participants who attended project 4. We
excluded those aged 49 or younger (n=365) and who
did not attend project 3 (n=200). The final sample for
the current study was 690 (see Appendix A Flow chart).
Procedure
The MIDUS II Project 1 included self-administered
questionnaires on sociodemographic information.
Project 3, which included a series of cognitive tests,
was administered over the telephone. Project 4 included
a two-day visit to one of the participating General
Clinical Research Centers (GCRCs). Of relevance to
the current study, on Day 1, participants completed a
detailed medical history interview, medication review,
and physical assessment with GCRC clinicians as well
as self-administered questionnaire on psychobehavioral
characteristics. On Day 2, a fasting blood sample was
collected between 08:00 AM and 10:00 AM, and appropri-
ately stored. Institutional Review Board approval was
obtained for each study project at each study site, and
informed written consent was obtained from all partici-
pants (Dienberg Love et al., 2011).
Measures
Frailty. Frailty was measured based on the validated
Fried Frailty measure, which assess individuals on five
frailty characteristics: physical inactivity, weakness,
exhaustion, unintentional weight loss, and slowness
(Fried et al., 2001). We first developed four continu-
ous (i.e., grip strength, exhaustion, weight change,
and walking speed) and one dichotomous (i.e., physical
inactivity) variable for the individual indicators of
frailty. Except physical inactivity, all other indicators
were dichotomized into criteria variables based on
cutoff scores of Fried et al. (Fried et al., 2001) (see
Appendix B Table A1). For the five frailty criteria, those
with zero criteria were considered non frail, with one to
two criteria were pre-frail, and three or more criteria
were frail. However, only 19 participants were classified
as frail (2.8%); therefore, the subgroups with pre-frail
and frail were combined. Pre-frail and frail participants
were similar in their demographic and health character-
istics, except that sleep quality was significantly worse
among frail participants. Data on at least one of the
frailty indicators was missing for 26 participants; these
individuals were not included in the analyses. There
were no significant differences in any demographic
information between participants with and without
frailty data.
65Cognition, frailty, and MetS
Copyright # 2014 John Wiley & Sons, Ltd. Int J Geriatr Psychiatry 2015; 30: 64–71
Cognition. Two sets of neuropsychological tests were
conducted over the phone: the Brief Test of Adult
Cognition by Telephone (BTACT) (Tun and
Lachman, 2006) and the Stop and Go Switch Task
(Tun and Lachman, 2008). Two domains, episodic
memory (EM) and executive function (EF) had been
derived using exploratory and CFA of the seven
cognitive tests previously (Lachman et al., 2011). EM
and EF decline earliest in the aging process (Park
and Reuter-Lorenz, 2009). Two tests of episodic verbal
memory (Word List Immediate and Delayed Recall)
from BTACT were used to determine EM; the
measures of working memory span (Digits Backward),
verbal fluency (Category Fluency), inductive reasoning
(Number Series), and processing speed (Backward
Counting) from BTACT and attention switch and
inhibitory control (called “inhibition” thereafter)
from Stop and Go Switch Task were used to determine
EF (Lachman et al., 2011).
Metabolic syndrome. Metabolic syndrome was originally
defined using the National Cholesterol Education
Program Adult Treatment Panel III guidelines (2001),
including the following: (a) abdominal obesity (waist
circumference > 102 cm in men and > 88 cm in
women), (b) triglyceride level ≥ 150mg/dL, (c) low
high-density lipoprotein cholesterol (<40mg/dL in
men and <50mg/dL in women), (d) systolic blood
pressure (BP) ≥ 130mm Hg and/or diastolic BP
≥ 85mm Hg or use of antihypertensive medication,
and (e) high fasting glucose (≥110mg/dL or use of
anti-diabetic medication). Fasting glucose was
unavailable; hence, we used blood hemoglobin A1c
(HbA1c) ≥ 7% or use of anti-diabetic medication as the
criterion for hyperglycemia. BP was averaged over three
measurements during the physical exam. Lipid and
HbA1c levels were measured using standard fasting
blood draw procedures. All prescription medications
were documented based on the original bottles the
participants brought to the GCRC.
Additionally, literature consistently supports a
positive association between the level of C-reactive
protein (CRP) and adverse cardiovascular events, and
suggests that adding CRP to the profile of MetS would
enhance the predictive value of MetS (Ridker et al.,
2004; Abraham et al., 2007). In 2004, the National
Heart Lung Blood Institute/American Heart Associa-
tion report emphasized the importance of considering
CRP as a “metabolic risk factor” (Grundy et al., 2004).
Therefore, in the present study, we utilized a modified
MetS profile that includes CRP. CRP was analyzed
using a particle enhanced immunonepholometric
assay (BNII nephelometer, Dade Behring Inc.,
Deerfield, IL, USA) with acceptable intra-assay and
inter-assay coefficients (<10%). There is no consistent
clinically meaningful cutoff score for CRP; thus, we
analyzed CRP as a continuous variable. In the present
study, we added CRP to the five established MetS
components to determine MetS using CFA. The CFA
approach, instead of simply applying a cutoff score
for MetS, was used in previous study without consider-
ing CRP (Stevenson et al., 2012).
Covariates. Demographic and health characteristics
were chosen based on the frailty related literature
(Robertson et al., 2013). Demographic characteristics
included age, sex, and education. Active alcohol intake
was considered if the participant was drunk one or
more days/week. The use of corticosteroids medica-
tions was recorded based on the original bottles
brought in by participants for their overnight stay at
the GCRC. History of stroke and cancer were collected
on the basis of participant self-report. Sleep quality
was assessed with the Pittsburg Sleep Quality Inven-
tory (37). A global sleep quality score was calculated
by summing the responses to all items across seven
domains with higher scores indicating better sleep.
Data analysis
Due to its skewed distribution, CRP was log transformed.
Descriptive analysis was performed. To examine the
association between MetS, cognition (EF or EM), and
frailty, we conducted SEM with the measurement model
consisting of a CFA on the items used for the MetS and
the cognition measures and the structural model
consisting of an interaction between two latent variables
(Figure 1) using Mplus 7.0 (MPlus, Version 7.0 (Com-
puter Software) Muthen and Muthen: Los Angeles, CA)
(Muthen and Muthen, 1998). The model was estimated
using maximum likelihood estimation (Klein and
Moosbrugger, 2000), including estimating a random effect
and maximum likelihood estimator with robust standard
errors. The dependent variable (i.e., frailty) and MetS
components (except CRP) were defined as dichotomous
variables, whereas CRP and cognitionmeasures were con-
tinuous variables. Age, sex, corticosteroids, sleep quality,
history of cancer, history of stroke, and alcohol intake were
controlled setting them as correlates of the dependent var-
iable. For multilevel analysis including an interacting term
between latent variables, comparative model fit indices
have not been developed in Mplus. We reported absolute
model fit indices (Akaike Information Criteria and Bayes-
ian Information Criteria), and likelihood ratio chi-square
test defined as the difference between the log likelihood
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of the present model (with interacting term) and nested
model (without interacting term) multiplied by (2), as
suggested by Dr. Muthen (http://www.statmodel.com/
discussion/messages/11/862.html?1193666052). If there
were any significant interactions between cognition (EF or
EM) and MetS, we next examined the association between
cognition and frailty by stratifyingMetS at 0 vs. 1. Statistical
significance was evaluated using an overall α level of 0.05.
Figure 1 (a) Interaction between metabolic syndrome (MetS) and executive function (EF) on frailty. Akaike Information Criteria (AIC) = 25,237.08,
Bayesian Information Criteria (BIC) = 25,433.934. Note. Five cases were missing. Age, sex, corticosteroids, sleep quality, history of cancer, history of
stroke, and alcohol taken were controlled. *p< 0.05; **p< 0.01; ***p< 0.001. †Interaction term between MetS and EF. 1Dichotomous variable; 2-
continuous variable. (b) Interaction between MetS and episodic memory (EM) on frailty. AIC = 14,511.16, BIC = 14,667.74. Note. Six cases were
missing. Age, sex, corticosteroids, sleep quality, history of cancer, history of stroke, and alcohol taken were controlled. **p< 0.01; ***p< 0.001.
†Interaction term between MetS and EM. 1Dichotomous variable; 2continuous variable.
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Results
Table 1 shows the descriptive data. The average age of
the total sample was 63.23 years and 45.1% was male.
A total of 287 (43.2%) participants were considered
pre-frail/frail. The most prevalent frailty characteristic
was physical inactivity (21.4%), whereas the least
prevalent was slowness (5.1%).
Figure 1(a) shows the association between MetS, EF,
and frailty. For the CFA (measurement) portion of the
model, when setting obesity as the reference, all the
relevant factor indicators (CRP, high triglycerides, high
BP, low high-density lipoprotein, and hyperglycemia)
were significant for MetS. When setting working
memory as reference, all the relevant factor indicators
(verbal fluency, inductive reasoning, processing speed,
and inhibition) were significant for EF. For the
structural model, there was no significant association
between MetS and EF, the two latent variables
(B=0.80, SE=0.07, p=0.25). There were significant
main effects of MetS (B=0.22, SE=0.07, OR=1.24,
p=0.003) and EF (B=0.48, SE=0.22, OR=0.62,
p=0.033) as well as interacting effect between MetS
and EF (B=0.34, SE=0.17, OR=0.71, p=0.049)
on frailty, controlling for covariates. Chi-square testing
(χ2 = 5640.72, df=3, p< 0.001) indicated the present
model was a significant improvement to the nested
model (without interacting term). To further interpret
the interaction effect between EF andMetS, stratification
analysis was conducted. MetS was set to equal 0 (MetS
not present) or 1 (MetS present) (Figure 1(a)). A
stronger association of lower EF and increased likeli-
hood of frailty existed in individuals with MetS than
without MetS.
Figure 1(b) shows the association betweenMetS, EM,
and frailty. For the measurement model, factors were all
significant for MetS, and when setting immediate recall
as reference, delayed recall was significant for EM. For
the SEM part, there was significant association between
MetS and EM (B=0.59, SE=0.25, p=0.017), and
significant association between MetS and frailty
(B=0.21, SE=0.07, OR=1.23, p=0.002). There was
no significant main effect of EM (B=0.02, SE=0.05,
OR=0.98, p=0.70) or interacting effect between MetS
and EM (B=0.04, SE=0.03, OR=0.96, p=0.18) on
frailty. Chi-square testing (χ2 =2.01, df=1, p=0.16)
indicated the present model was not a significant
improvement to the nest model.
Discussion
To the best of our knowledge, this is the first study
examining the relationship between MetS, cognition,
and frailty using both measurement and structural
models via SEM. Such modeling techniques allow a
sophisticated examination of the complex associations
between multiple components of MetS and cognition
in relation to frailty. That is, by including measure-
ment models for cognition and MetS, the estimation
of measurement error that is derived from the CFA
is then incorporated into the estimates of the parame-
ters within the structural model making the estimates
of the relationships within the structural model more
robust. Our findings support previous investigators’
suggestions that CRP be considered an indicator of
MetS (Grundy et al., 2004) and replicated the CFA
for the two domains of cognition (Lachman et al.,
2011). We found that having MetS significantly
increased the likelihood of being frail and that
Table 1 Demographic and health data
Characteristics Values
Age (mean, SD) 63.23 (9.15)
Education a
• High school graduate or less 177 (25.7%)
• Some college 196 (28.4%)
• College graduate or more 315 (45.6%)
Male (n, %) 311 (45.1%)
Alcohol intake (n, %) 464 (67.2%)
Corticosteroids (n, %) 99 (14.3%)
Stroke (n, %) b 3 (0.4%)
Cancer (n, %) c 102 (14.8%)
Sleep quality (mean, SD) 5.75 (3.35)
Metabolic syndrome component
• Obesity (n, %) 365 (52.9%)
• C-reactive protein (mean, SD)d 0.24 (1.02)
• High triglycerides (n, %) 194 (28.1%)
• High blood pressure (n, %) 426 (61.7%)
• Low high-density lipoprotein (n, %) 191 (27.7%)
• Hyperglycemia (n, %) 85 (12.3%)
EF
• Working memory (mean, SD) 4.95 (1.39)
• Verbal fluency (mean, SD) 19.23 (5.60)
• Inductive reasoning (mean, SD) 2.40 (1.49)
• Processing speed (mean, SD) 37.19 (10.15)
• Inhibitione (mean, SD) 3.82 (0.63)
Episodic memory
• Immediate recall (mean, SD) 6.76 (2.16)
• Delayed recall (mean, SD) 4.36 (2.46)
Frailty (n, %) 287 (43.2%)
• Physical inactivity (n, %) 148 (21.4%)
• Exhaustion (n, %) 84 (12.2%)
• Unintentional weight loss (n, %) 62 (9.0%)
• Weakness (n, %) 57 (8.3%)
• Slowness (n, %) 35 (5.1%)
SD, standard deviation.
a3 cases were missing;
b5 cases were missing;
c3 cases were missing.
dLog transformed.
eReversed coded, higher indicating better.
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performing better on EM tasks, but not EF, was asso-
ciated with a significantly lower likelihood of MetS.
Worse performance on EF tasks, but not EM, was asso-
ciated with a significantly higher likelihood of being
frail. There was a significant interacting effect between
MetS and EF, but not EM, on frailty. Further stratifica-
tion analysis indicated that having MetS strengthened
the relationship between EF and being frail in the
individuals with MetS, and individuals with executive
dysfunction were those more likely to be frail.
We found several significant bi-correlations be-
tween frailty, MetS, and cognition that are consistent
with the literature. First, although previous work
found those with MetS are, in general, more likely to
exhibit poor cognition (Panza et al., 2011), memory
may have a more prominent association with MetS
than other cognitive domains, such as EF
(Komulainen et al., 2007; Hassenstab et al., 2010),
which was replicated in the present study. Second,
consistent to previous studies, frailty was associated
with executive dysfunction (Robertson et al., 2013).
Through the function of the frontal cortex and white
matter, EF regulates motor planning, which is critical
for carrying out movements (i.e., grip and gait) that
can maintain both upper and lower extremity function
(Ble et al., 2005; MacDonald et al., 2011). When
declines in EF are experienced, declines in physical
function may manifest as decreased grip strength and
walking speed. EM was not significantly related to
frailty. This is likely due to our approach to frailty as
a physical phenomenon. Encoding and storaging
memory is not in motor planning. Finally, we found
a significant association between MetS and frailty
regardless of the type of cognition. Such a relationship
is likely attributed to the degrading effects of metabolic
risk factors (e.g., altered markers of carbohydrate
metabolism, elevated inflammation markers, hyper-
tension and coagulation, and insulin resistance) on
bone and muscle tissue that are related to frailty
(Barzilay et al., 2007; Barzilay and Stein, 2011).
Metabolic syndrome was supported as a moderator of
the relationship between EF, but not EM, and frailty.
Chronic inflammation, insulin resistance, and BP
regulation from MetS may be involved in supporting
the association. First, individuals with MetS are
predisposed to developing chronically elevated levels of
inflammation that can negatively affect EF. CRP is one
of the most consistently identified inflammatory factors
regulating the relationship between cognition and frailty
(Barzilay and Stein, 2011). A recent study found that
CRP mediated the relationship between muscle strength
and cognitive decline in women (Canon and Crimmins,
2011). Second, Abbatecola et al. (2007) proposed insulin
resistance might also explain the relationship between
cognition and frailty. That is, insulin modulates glucose
use through receptors located in the hippocampus and
frontal cortex, which is in particular related to EF;
meanwhile, insulin resistance causes an imbalance to-
ward catabolism, presenting as problems related to
muscle mass and strength (Abbatecola et al., 2007). Al-
though we did not directly measure insulin resistance, it
is usually highly correlated to hemoglobin A1c levels. Fi-
nally, there is no study examining disrupted circulation
as a mechanism. However, arterial BP regulates the
changes in tissue perfusion, which potentially explain
the degree of physiological reserve/frailty (Fattori et al.,
2013). Meanwhile, several studies suggest that arterial
BP is linked to cerebral blood flow and can directly in-
fluence cognitive function (Panza et al., 2011). In indi-
viduals with MetS, these three pathways may be
disrupted and increase the likelihood of experiencing
declines in EF and developing frailty. In contrast, in
those without MetS, these pathological processes may
not reach the threshold to disturbing the brain’s ca-
pacity in regulating motor process that likely play a
role in the development of frailty. Very few studies
have tested these potential biological pathways as links
between cognitive decline and frailty, especially in
groups vulnerable to disruption in these biological
pathways (i.e., individuals with MetS).
Presently, there is an emphasis in aging research to
develop interventions that can address co-morbidities
simultaneously. A recent aerobic exercise intervention
simultaneously improved frailty indicators and cogni-
tive function (Langlois et al., 2013). A well-established
lifestyle intervention, Diabetes Prevention Program,
which includes both dietary and physical activity
interventions, improves MetS related conditions such
as obesity and glucose level (Goldberg and Mather,
2012). Given the success of these interventions and
the close relationships observed in this current study
among EF, MetS, and frailty, it is reasonable to propose
that any of these interventions may be effective in
preventing or managing MetS or preventing cognitive
decline and frailty in individuals with MetS.
The findings from this study must be interpreting
in the light of certain study limitations. First, The
sample was relatively young and reported relatively
high levels of physical functioning, which resulted in
reduced variability in our frailty measuring requiring
the combination of the pre-frail and frail groups.
However, because MetS occurs relatively early
compared with many other chronic conditions, it is
important to examine its influence on cognition and
frailty in other age groups than merely older adults
(Weiss et al., 2013). Second, although SEM is
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appropriate for testing established conceptual frame-
work, the cross-sectional nature of this study still
limits our ability to deduce the directionality of the
tested relationships. Third, major cardiovascular
events (e.g., heart attack) are closely linked to MetS.
Future studies may consider take into account the
effect of this factor in confounding the relationships
between MetS, frailty, and cognition. Finally, we were
not able to replicated the MetS or Fried frailty measure
exactly. For MetS measure, given the unavailable of
fasting glucose, we used HbA1c, which may not be
sensitive to capture the recent onset of elevation in
glucose. Regarding frailty measure, previous studies
have also used modified versions of this measure and
found significant associations between frailty and
various markers of poor health (i.e., number of chronic
diseases) (e.g., Espinoza et al., 2012). Previously ob-
served relationships between frailty and various
markers of health (i.e., lower levels of EF and MetS)
were observed in our study, providing concurrent va-
lidity for our frailty measure.
Conclusion
This study provides a new prospect on the relationship
between cognition and frailty within the context of
specific health condition, MetS. If these same associa-
tions are observed in a prospective study, targeting in-
dividual with MetS for interventions designed for the
prevention of EF and/or frailty may be a worthwhile
endeavor in an attempt to prevent multiple chronic




• Executive function and metabolic syndrome are
associated with the likelihood of being frail.
• Metabolic syndrome moderates the association
between executive function and being frail.
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Table A1. The Fried frailty characteristics in the present study
Characteristics Measurements and frailty indicators Frailty criteria
Physical
inactivity*
Using one item, “Do you engage in at
least 20minutes of physical activity at
least 3 times per week?” Participants
reporting “No” were considered to
have physical inactivity.
Participants reporting “No”




Grip strength was assessed using
a handheld dynamometer. The average
of three trials in the dominant hand was used.
The lowest 20% by body mass
index and gender were used to
determine the weakness.
Exhaustion Using two items from the Center for Epidemiologic
Studies Depression Scale: (a) “I felt that everything
I did was an effort” and (b) “I could not get going.”
Participants responding “a moderate
amount of the time (3–4days)” or “most




Calculating percent weight loss in the participants
between their completion of the self-administered
questionnaire at project 1 and their
overnight stay at project 4.
In an attempt to capture intentionality,
individuals who lost 5% or more of their
body weight and did not report losing
weight due to diet and exercise were
considered to have unintentionally lost weight.
Slowness/walking
speed
Calculating feet per second using the time, in seconds,
it took participants to walk 50 ft at their usual pace.
The slowest 20% by gender and height
were used to determine the slowness.
*Physical inactivity was the only variable that frailty indicator and criteria were the same variable.
Appendix B: Flow chart
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